Screener
Nurix Therapeutics, Inc. NRIX Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Collaboration revenue | $9,043 | $14,056 | $15,295 | $32,509 |
| License revenue | — | 30,000 | — | 30,000 |
| Total revenue | 9,043 | 44,056 | 15,295 | 62,509 |
| Operating expenses: | ||||
| Research and development | 87,653 | 78,096 | 171,789 | 147,759 |
| General and administrative | 15,594 | 14,282 | 30,205 | 25,936 |
| Total operating expenses | 103,247 | 92,378 | 201,994 | 173,695 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s total revenue?
- Nurix Therapeutics, Inc. (NRIX) reported total revenue of $9.04M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s total revenue changed year-over-year?
- Nurix Therapeutics, Inc.'s total revenue decreased by 79.5% year-over-year, from $44.06M to $9.04M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s total revenue has grown at a 29.6% compound annual growth rate (CAGR), from $29.75M to $83.98M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Nurix Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude